In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?

A word of caution regarding the use of G-CSF in the setting of using ATG for GVHD prophylaxis. We published in 2021 (Orfali et al., PMID 34507002) a multicenter retrospective analysis of the interaction between ATG and post-transplantation G-CSF on allogeneic HCT outcomes for myeloid malignancies an...

There are variable practices with the use of filgrastim post-allogeneic HSCT to facilitate engraftment. Older publications linked its use to a higher incidence of acute graft versus host disease and delayed platelets recovery (Remberger et al., PMID 12838288, Ringdén et al., PMID 14691124, and Mohty...